The Valley Desk

NCT01807546 · Interventional trial

Oral Rigosertib for Squamous Cell Carcinoma

Overall registry status Completed

Phase 2

Conditions Anal Squamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma, Penile Squamous Cell Carcinoma, Skin Squamous Cell Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov